Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 12, 2011
Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★)R Reshef, S Vardhanabhuti, M R Luskin, et al.
Transplantation|May 26, 2001
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patientsD E Tsai, C L Hardy, J E Tomaszewski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Treatment of PTLD with rituximab or chemotherapyR L Elstrom, C Andreadis, N A Aqui, et al.
Bone Marrow Transplantation|October 14, 2008
Second auto-SCT is safe and effective salvage therapy for relapsed multiple myelomaR L Olin, D T Vogl, D L Porter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative DisorderM R Luskin, D S Heil, K S Tan, et al.
Bone Marrow Transplantation|March 15, 2005
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantationA W Loren, S M Luger, E A Stadtmauer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 4, 2008
EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trialD E Tsai, L Douglas, C Andreadis, et al.
Medical Oncology (Northwood, London, England)|January 5, 2000
Stem cell transplantation for metastatic breast cancer: analysis of tumor contaminationE A Stadtmauer, D E Tsai, C J Sickles, et al.
Bone Marrow Transplantation|October 6, 2005
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis, S J Schuster, E A Chong, et al.
Pageof 2